The Purpose of This Study is to Determine The Efficacy and Safety of a Systemic Hedgehog Pathway Antagonist (GDC-0449) in Patients With Basal Cell Nevus Syndrome (BCNS)
Conditions: Basal Cell Nevus Syndrome; Gorlin Syndrome Intervention: Drug: GDC-0449 Sponsors: Children's Hospital & Research Center Oakland; Genentech Active, not recruiting - verified July 2011